NCT01441258 Adaptation of Dialectical Behavior Therapy Skills-Groups for Individuals With Suicidal Ideation and Depression Status COMPLETED Phase NA
NCT01438242 An Open Label Study of the Geneceptâ„¢ Assay in Treatment Resistant Depression Status WITHDRAWN Phase NA
NCT01437657 MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy Status COMPLETED Phase PHASE2
NCT01436175 SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study Status TERMINATED Phase PHASE3
NCT01436162 Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01436149 Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01435759 SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01432457 Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE4
NCT01431001 Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression Status COMPLETED Phase NA
NCT01430767 Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder Status COMPLETED Phase N/A
NCT01429831 Aripiprazole for the Augmentation of Antidepressant Therapy Status COMPLETED Phase PHASE4
NCT01428661 Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE2/PHASE3
NCT01427439 A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder Status COMPLETED Phase N/A
NCT01426516 Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1) Status TERMINATED Phase NA
NCT01422213 Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3